methylprednisolone has been researched along with B-Cell Chronic Lymphocytic Leukemia in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.00) | 18.7374 |
| 1990's | 12 (24.00) | 18.2507 |
| 2000's | 15 (30.00) | 29.6817 |
| 2010's | 15 (30.00) | 24.3611 |
| 2020's | 6 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, D; Costa, MJ; Espada, E; F Lacerda, J; Lopes, C; Polo, B; Raposo, J; Vagos Mata, A | 1 |
| Bektaş, M; Özdemir, G | 1 |
| Arias-Martínez, A; Carriles, C; Menárguez-Blanc, R; Ordóñez-Fernández, L; Rosado-María, MC | 1 |
| Griskevicius, L; Matuzeviciene, R; Pileckyte, R; Sejoniene, J; Stoskus, M; Valceckiene, V; Zvirblis, T | 1 |
| Fazlic Dzankic, A; Ivic, M; Jaksic, O; Jonjic, Z; Lucijanic, M; Mitrovic, Z; Pejsa, V; Pirsic, M; Prka, Z; Stoos-Veic, T; Vrkljan Vuk, A | 1 |
| Budziszewska, BK; Długosz-Danecka, M; Gil, L; Hus, M; Iskierka-Jażdżewska, E; Jamroziak, K; Jurczak, W; Lech-Marańda, E; Osowiecki, M; Piszczek, W; Puła, B; Rybka, J; Salomon-Perzyński, A; Steckiewicz, P; Subocz, E; Szukalski, Ł; Szymczyk, A; Waszczuk-Gajda, A; Zaucha, JM | 1 |
| Argyraki, A; Boletis, I; Grigorakos, K; Lourida, P; Marinaki, S; Skalioti, C; Tsiakas, S | 1 |
| McClendon, EE; Suzuki, T; Tanawuttiwat, T | 1 |
| Balaratnasingam, C; Constable, IJ; Menghini, M; Raiter, J; Raja, V | 1 |
| Arnason, J; Brown, JR; Davids, MS; De Maeyer, G; Fernandes, SM; Fisher, DC; Francoeur, K; Hellman, JM; Jacobsen, ED; Kim, HT; LaCasce, AS; Langey, R; McDonough, M; Vartanov, AR; Yu, L | 1 |
| Fan, L; Li, JY; Shi, K; Wang, L; Xia, Y; Xu, W; Zhu, HY | 1 |
| Baquero-Sánchez, E; Conejo-Mir, J; De Zulueta-Dorado, T; López-López, R; Lorente-Lavirgen, AI; Pulpillo-Ruiz, A | 1 |
| Hamdan, A; Joyce, RM; Tzachanis, D; Uhlmann, EJ | 1 |
| Ai, H; Mi, R; Song, Y; Wei, X; Yin, Q | 1 |
| Almahasnah, E; Carvajal, T; Castro, JE; Chang, J; Choi, MY; James, DF; Kipps, TJ | 1 |
| Li, PP; Liang, SM; Liu, YX; Lu, K; Wang, X; Yao, QM; Yuan, T; Zhang, F; Zhu, XJ | 1 |
| Hsuan, JD; Lee, RW; Malik, R; Potts, MJ; Ramkissoon, YD | 1 |
| Bole, J; Castro, JE; Kipps, TJ; Rassenti, L; Sandoval-Sus, JD | 1 |
| Antoniou, C; Ioannidou, D; Katsambas, A; Pigaditou, A; Stefanaki, C; Tasidou, A | 1 |
| Boelens, J; Bracke, M; Derycke, L; Janssens, A; Lust, S; Offner, F; Philippé, J; Van Bockstaele, F; Van Gele, M; Vanhoecke, B | 1 |
| Bole, J; Castro, JE; Jain, S; James, DF; Kipps, TJ; Rassenti, L; Sandoval-Sus, JD | 1 |
| Ayemou, R; Koffi, KG; Kouakou, B; Meite, N; N'Dathz, E; Nanho, DC; Sanogo, I; Tolo, A | 1 |
| Fan, L; Hong, M; Li, JY; Miao, KR; Qian, SX; Xu, W | 1 |
| Cao, X; Dong, HJ; Fang, C; Hong, M; Li, JY; Miao, KR; Wang, DM; Xu, W; Zhu, DX | 1 |
| Degulys, A; Gineikiene, E; Griskevicius, L; Jurgutis, M; Pileckyte, R; Sejoniene, J; Stoskus, M; Valceckiene, V; Zvirblis, T | 1 |
| Barajas-Gamboa, JS; Castro, JE; Diaz-Perez, JA; Horton, JM; Kipps, TJ; Weidner, N | 1 |
| Agrawal, S; Allsup, D; Bloor, A; Blundell, J; Carruthers, S; Catovsky, D; Dearden, CE; Devereux, S; Dodd, J; Dodd, S; Follows, GA; Hamblin, TJ; Heartin, E; Hillmen, P; Jackson, R; Johnson, GG; Kruger, A; Matutes, E; Oates, M; Oscier, D; Pettitt, AR; Proctor, S; Radford, JA; Rawstron, A; Schuh, A | 1 |
| Airagnes, G; Garre, JB; Gohier, B; Rouge-Maillart, C | 1 |
| Gergely, L; Illés, A; Remenyik, E; Vadász, G; Váróczy, L | 1 |
| RAAB, W | 1 |
| Bosanquet, AG; Bowcock, SJ; Catovsky, D; Douglas, ID; Grech, H; Joshi, R; Lakhani, AK; Mackie, PH; Matutes, E; Ropner, JE; Thornton, PD | 1 |
| Bosanquet, AG; Daniel, PT; Dörken, B; Hummel, M; Sturm, I | 1 |
| Matutes, E; Oscier, D; Pettitt, AR | 1 |
| Ames, PR; Aw, D; Rainey, MG | 1 |
| Bowen, DA; Call, TG; Jelinek, DF; Jenkins, GD; Kay, NE; Schwager, SM; Shanafelt, TD; Van Dyke, DL; Zent, CS | 1 |
| Catovsky, D; Dearden, CE; Dungarwalla, M; Evans, SO; Matutes, E; Riley, U | 1 |
| Bosanquet, AG; Catovsky, D; Crotty, GM; McCann, SR; Mills, MJ | 1 |
| Chandra, J; Keating, M; McConkey, DJ; McDonnell, TJ; Plunkett, W; Reed, JC; Wright, S | 1 |
| Cole, I; Cunningham, I; Dao, LP; Dean, MG; Mulligan S, P | 1 |
| Audouin, J; Brousse, N; Delmer, A; Lavergne, A; Molina, T; Rambaud, JC; Ruskoné-Fourmestraux, A | 1 |
| Coutinho, AK; de O Santos, M; del Giglio, A; Feher, O; Pinczowski, H | 1 |
| Beaufils, H; Cacoub, P; Carde, P; Charlotte, F; Davi, F; Ginsburg, C; Godeau, P; Tazi, Z | 1 |
| Lundberg, LG; Samuelsson, J | 1 |
| Brugiatelli, M; Callea, I; Cartisano, G; Dattola, A; Irrera, G; Morabito, F; Rodinò, A | 1 |
| Antich Rojas, J; Balaguer, H; Cladera, A | 1 |
| Dreger, P; Glass, B; Kuse, R; Löffler, H; Schmitz, N; Schoch, R; Sonnen, R; Uharek, L; von Neuhoff, N | 1 |
| Catovsky, D; Hamblin, M; Lakhani, AK; Matutes, E; Thornton, PD; Treleaven, JG | 1 |
| Bosanquet, AG; Bosanquet, MI | 1 |
| Cowled, PA; Forbes, IJ; Giannakis, C; Zalewski, PD | 1 |
| Gallurt, P; Gil, JL; Millán, J; Oyonarte, S; Senra, A | 1 |
2 review(s) available for methylprednisolone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
[Fresh frozen plasma and Rituximab in combination with high dose methylprednisolone for the treatment of relapsed and refractory chronic lymphocytic leukemia: three cases report and literatures review].
Topics: Antibodies, Monoclonal, Murine-Derived; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Plasma; Rituximab; Treatment Outcome | 2014 |
The emergence of Hodgkin's disease in a patient with long-standing chronic lymphocytic leukemia--case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Disease Progression; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Vincristine | 1997 |
9 trial(s) available for methylprednisolone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 17; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Recurrence; Survival Rate | 2014 |
[High-dose methylprednisolone for the treatment of refractory chronic lymphocytic leukemia].
Topics: Adult; Aged; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Treatment Outcome | 2009 |
Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Hyperglycemia; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Risk Factors; Rituximab; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53 | 2011 |
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.
Topics: Academies and Institutes; Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gene Deletion; Genes, p53; Humans; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Logistic Models; Male; Methylprednisolone; Middle Aged; Proportional Hazards Models; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome; United Kingdom | 2012 |
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Remission Induction; Tumor Cells, Cultured | 2003 |
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Immunotherapy; Infection Control; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Rituximab; Salvage Therapy; Vidarabine | 2008 |
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fatal Outcome; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplastic Stem Cells; Palliative Care; Pilot Projects; Prednisolone; Prednisone; Remission Induction; Staining and Labeling; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vidarabine; Vinca Alkaloids; Vincristine | 1995 |
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methotrexate; Methylprednisolone; Middle Aged; Mitomycins; Prednisone; Prospective Studies; Treatment Outcome; Vincristine | 1998 |
High dose methyl prednisolone in refractory chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Glucocorticoids; Humans; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged | 1999 |
39 other study(ies) available for methylprednisolone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.
Topics: Aged; Aged, 80 and over; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Progression-Free Survival; Retrospective Studies; Rituximab | 2021 |
Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; COVID-19; COVID-19 Drug Treatment; Cyclophosphamide; Cytokine Release Syndrome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Rituximab; Treatment Outcome | 2022 |
Autoimmune hemolytic anemia, adverse event to venetoclax.
Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Recurrence; Rituximab; Salvage Therapy; Sulfonamides; Vincristine | 2019 |
Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Prospective Studies; Rituximab | 2019 |
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal, Humanized; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Premedication | 2020 |
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Prognosis; Proto-Oncogene Proteins c-bcr; Purines; Quinazolinones; Retrospective Studies; Salvage Therapy; Survival Rate; Tumor Suppressor Protein p53 | 2020 |
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.
Topics: Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Coronavirus Infections; COVID-19; Creatinine; Cryoglobulinemia; Cyclophosphamide; Enzyme Inhibitors; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Greece; Humans; Hydroxychloroquine; Immunocompromised Host; Immunologic Factors; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lung; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Rituximab; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Arrhythmia in Bone Marrow Transplant Unit.
Topics: Adult; Atrioventricular Block; Bone Marrow Transplantation; Bradycardia; Electrocardiography; Female; Graft vs Host Disease; Heart Block; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Diseases; Lung Diseases; Methicillin-Resistant Staphylococcus aureus; Methylprednisolone; Mycophenolic Acid; Pneumonia, Staphylococcal; Skin Diseases; Tacrolimus; Transplantation, Homologous | 2017 |
ACUTE RETINAL NECROSIS ASSOCIATED WITH HERPES ZOSTER VACCINATION.
Topics: Aged; Antiviral Agents; Eye Infections, Viral; Glucocorticoids; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpes Zoster Vaccine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Retinal Necrosis Syndrome, Acute; Vaccination | 2021 |
Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 17; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Prognosis; Sequence Deletion; Transplantation, Homologous; Treatment Outcome; Tumor Suppressor Protein p53 | 2019 |
[High-dose methylprednisolone with Rituximab and fresh frozen plasma in the treatment of six patients with B-cell lymphoproliferative disorders harboring TP53 abnormalities].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Lymphoproliferative Disorders; Methylprednisolone; Rituximab; Tumor Suppressor Protein p53 | 2019 |
Pruritic nodules and plaques on the arms with blisters in a patient with chronic lymphocytic leukemia.
Topics: Anti-Bacterial Agents; Blister; Cellulitis; Eosinophilia; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Pruritus | 2014 |
Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoantigens; Bendamustine Hydrochloride; CD52 Antigen; Combined Modality Therapy; Consciousness Disorders; Gangliosides; Glycoproteins; Guillain-Barre Syndrome; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Miller Fisher Syndrome; Nitrogen Mustard Compounds; Plasmapheresis; Remission Induction; Rituximab; Virus Activation | 2014 |
Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoid Enhancer-Binding Factor 1; Methylprednisolone; Proto-Oncogene Proteins c-myc; RNA, Messenger; Time Factors; Up-Regulation; Wnt Signaling Pathway | 2015 |
Bilateral infiltrative disease of the extraocular muscles: a rare clinical presentation of early stage chronic lymphocytic leukemia.
Topics: Aged; Antigens, CD; Combined Modality Therapy; Functional Laterality; Glucocorticoids; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Methylprednisolone; Oculomotor Muscles; Orbital Neoplasms; Radiotherapy | 2008 |
Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Myeloablative Agonists; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome; Vidarabine | 2008 |
Recurrent penile ulcer as a manifestation of chronic lymphocytic leukaemia.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Penile Diseases; Recurrence; Skin Ulcer; Treatment Outcome | 2008 |
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
Topics: Adrenal Cortex Hormones; Annexin A5; Apoptosis; Chlorambucil; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Enzymologic; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Plasmids; Prognosis; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Syk Kinase; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2009 |
Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Prognosis; Rituximab; Survival Rate; Tissue Distribution | 2009 |
[Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cote d'Ivoire; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Sex Distribution; Vincristine | 2009 |
High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Agents; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Remission Induction; Treatment Outcome; Vidarabine | 2010 |
Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Humans; Immunoglobulins; Kidney Diseases; Kidney Glomerulus; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Rituximab; Treatment Outcome | 2012 |
[Homicide and acute cortico-induced psychosis: A case report].
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Early Diagnosis; Fatal Outcome; Homicide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Psychoses, Substance-Induced; Substance Withdrawal Syndrome | 2012 |
Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Plasma Exchange; Prednisone; Remission Induction; Vincristine | 2003 |
[HERPES ZOSTER AS AN ISOMORPHOUS EFFECT OF STIMULATION IN CHRONIC LYMPHATIC LEUKEMIA].
Topics: Antineoplastic Agents; Blood Transfusion; Herpes Zoster; Herpesvirus 3, Human; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Methylprednisolone; Tetracycline; Toxicology | 1964 |
In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Topics: Aged; Antineoplastic Agents; Apoptosis; Arginine; Chlorambucil; Codon; Cyclophosphamide; DNA Mutational Analysis; Doxorubicin; Drug Resistance, Neoplasm; Female; Gamma Rays; Gene Expression Regulation, Neoplastic; Genes, p53; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Prognosis; Proline; Vidarabine Phosphate; Vincristine | 2005 |
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Genes, p53; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged | 2006 |
Campath in haemolytic anaemia and chronic lymphatic leukaemia: an unsuccessful case.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Autoimmune Diseases; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Lymphocytes; Male; Methylprednisolone; Models, Biological; Time Factors; Treatment Outcome | 2007 |
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy | 2007 |
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; DNA, Neoplasm; Endonucleases; Glucocorticoids; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Mitoxantrone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Vidarabine | 1996 |
Chronic lymphocytic leukaemia with upper airway obstruction.
Topics: Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Dexamethasone; Doxorubicin; Dyspnea; Female; Humans; Hydrocortisone; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Prednisone; Tonsillar Neoplasms; Tonsillectomy; Vincristine | 1996 |
Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs.
Topics: Adult; Aged; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Female; Gastrointestinal Neoplasms; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Polyps; Prednisolone; Prospective Studies; Vincristine | 1997 |
Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids.
Topics: Adult; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Tumor Lysis Syndrome | 1997 |
Sjögren's syndrome with acute renal failure caused by renal pseudolymphoma.
Topics: Acute Kidney Injury; Glucocorticoids; Humans; Kidney; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Prednisone; Sjogren's Syndrome | 1996 |
In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemia.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Apoptosis; Chlorambucil; Drug Interactions; Drug Synergism; Humans; Lethal Dose 50; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Pregnenediones | 1997 |
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chlorambucil; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Hydrocortisone; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine; Vincristine | 1997 |
Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chlorambucil; Cladribine; Comorbidity; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Middle Aged; Neoplastic Stem Cells; Palliative Care; Pentostatin; Prednisolone; Prognosis; Staining and Labeling; Tumor Cells, Cultured; Vidarabine; Vincristine | 2000 |
Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aurintricarboxylic Acid; Cell Death; Colchicine; DNA Damage; Electrophoresis, Agar Gel; Etoposide; Humans; Isoquinolines; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Phorbol 12,13-Dibutyrate; Piperazines; Tumor Cells, Cultured | 1992 |
[Autoimmune hemolytic anemia, complement-mediated by warm reactive antibodies, associated with lymphoma].
Topics: Anemia, Hemolytic, Autoimmune; Antibodies; Antineoplastic Agents; Complement C3; Coombs Test; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged | 1988 |